CCAP Crescent Capital BDC Forecast, Technical & Fundamental Analysis

CCAP's RSI Oscillator is sitting in oversold zone for 2 days

It is expected that a price bounce should occur soon.

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +0.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where CCAP advanced for three days, in 188 of 316 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.

CCAP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CCAP as a result. In 40 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 51%.

The Moving Average Convergence Divergence Histogram (MACD) for CCAP turned negative on August 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 19 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 44%.

CCAP moved below its 50-day moving average on August 17, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CCAP crossed bearishly below the 50-day moving average on August 24, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 33%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CCAP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.

The Aroon Indicator for CCAP entered a downward trend on September 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 14 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.557) is normal, around the industry mean (3.383). P/E Ratio (27.900) is within average values for comparable stocks, (26.087). CCAP's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.018). CCAP has a moderately high Dividend Yield (0.161) as compared to the industry average of (0.088). P/S Ratio (51.546) is also within normal values, averaging (16.116).

The Tickeron SMR rating for this company is 68 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. CCAP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CCAP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.